New combo tackles tough bladder cancer in early trial
Disease control
Completed
This early-phase study tested a combination of two drugs—avelumab (an immunotherapy) and docetaxel (a chemotherapy)—in 21 people with advanced bladder cancer that had stopped responding to standard platinum chemotherapy. The main goals were to check safety and see if the combinat…
Phase: PHASE1 • Sponsor: Yousef Zakharia • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC